Drug repurposing for the treatment of COVID-19

• Glavni autori: Yuri Kato (Autor), Kazuhiro Nishiyama (Autor), Akiyuki Nishimura (Autor), Takamasa Noda (Autor), Kaori Okabe (Autor), Takahiro Kusakabe (Autor), Yasunari Kanda (Autor), Motohiro Nishida (Autor)
• Format: Knjiga
• Izdano: Elsevier, 2022-07-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Coronavirus disease 2019 (COVID-19) remains prevalent worldwide since its onset was confirmed in Wuhan, China in 2019. Vaccines against the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have shown a preventive effect against the onset and severity of COVID-19, and so...